|
Myocardial cardiomyopathy disease
Citations 251-260 of 479 total displayed.
|
Past content
(since Jan 1999):
|
- Basic Science Reports
Aldosterone, Through Novel Signaling Proteins, Is a Fundamental Molecular Bridge Between the Genetic Defect and the Cardiac Phenotype of Hypertrophic Cardiomyopathy
- Natalia Tsybouleva, Lianfeng Zhang, Suetnee Chen, Rajnikant Patel, Silvia Lutucuta, Shintaro Nemoto, Gilberto DeFreitas, Mark Entman, Blase A. Carabello, Robert Roberts, and A.J. Marian
Circulation 2004;109:1284-1291; published online before print as doi:10.1161/01.CIR.0000121426.43044.2B
[Abstract]
[Full text]
- Articles
Characterization of Left Ventricular Diastolic Function by Tissue Doppler Imaging and Clinical Status in Children With Hypertrophic Cardiomyopathy
- Colin J. McMahon, Sherif F. Nagueh, Ricardo H. Pignatelli, Susan W. Denfield, William J. Dreyer, Jack F. Price, Sarah Clunie, Louis I. Bezold, Amanda L. Hays, Jeffrey A. Towbin, and Benjamin W. Eidem
Circulation published March 15, 2004, doi:10.1161/01.CIR.0000124723.16433.31
[Abstract]
- Articles
Implantable Cardioverter/Defibrillator Therapy in Arrhythmogenic Right Ventricular Cardiomyopathy. Single-Center Experience of Long-Term Follow-Up and Complications in 60 Patients
- Thomas Wichter, Matthias Paul, Christian Wollmann, Tayfun Acil, Petra Gerdes, Obaidullah Ashraf, Tonny D.T. Tjan, Rasijd Soeparwata, Michael Block, Martin Borggrefe, Hans H. Scheld, Günter Breithardt, and Dirk Böcker
Circulation published March 8, 2004, doi:10.1161/01.CIR.0000121738.88273.43
[Abstract]
- Clinical Investigations and Reports
Usefulness of B-Type Natriuretic Peptide Assay in the Assessment of Symptomatic State in Hypertrophic Cardiomyopathy
- Barry J. Maron, Venkatakrishna N. Tholakanahalli, Andrey G. Zenovich, Susan A. Casey, Daniel Duprez, Dorothee M. Aeppli, and Jay N. Cohn
Circulation 2004;109:984-989; published online before print as doi:10.1161/01.CIR.0000117098.75727.D8
[Abstract]
[Full text]
- Basic Science Reports
Aldosterone, Through Novel Signaling Proteins, Is a Fundamental Molecular Bridge Between the Genetic Defect and the Cardiac Phenotype of Hypertrophic Cardiomyopathy
- Natalia Tsybouleva, Lianfeng Zhang, Suetnee Chen, Rajnikant Patel, Silvia Lutucuta, Shintaro Nemoto, Gilberto DeFreitas, Mark Entman, Blase A. Carabello, Robert Roberts, and A. J. Marian
Circulation published March 1, 2004, doi:10.1161/01.CIR.0000121426.43044.2B
[Abstract]
[Full text]
- Brief Rapid Communications
Predictors of Outcome After Alcohol Septal Ablation Therapy in Patients With Hypertrophic Obstructive Cardiomyopathy
- Su Min Chang, Nasser M. Lakkis, Jennifer Franklin, William H. Spencer, III, and Sherif F. Nagueh
Circulation 2004;109:824-827; published online before print as doi:10.1161/01.CIR.0000117089.99918.5A
[Abstract]
[Full text]
- Articles
Usefulness of B-Type Natriuretic Peptide Assay in the Assessment of Symptomatic State in Hypertrophic Cardiomyopathy
- Barry J. Maron, Venkatakrishna N. Tholakanahalli, Andrey G. Zenovich, Susan A. Casey, Daniel Duprez, Dorothee M. Aeppli, and Jay N. Cohn
Circulation published February 16, 2004, doi:10.1161/01.CIR.0000117098.75727.D8
[Abstract]
- Articles
Predictors of Outcome After Alcohol Septal Ablation Therapy in Patients With Hypertrophic Obstructive Cardiomyopathy
- Su Min Chang, Nasser M. Lakkis, Jennifer Franklin, William H. Spencer, III, and Sherif F. Nagueh
Circulation published February 16, 2004, doi:10.1161/01.CIR.0000117089.99918.5A
[Abstract]
- Correspondence
Short-Term Statin Therapy and Cardiac Function and Symptoms in Patients With Idiopathic Dilated Cardiomyopathy • Response
- Pim van der Harst, Adriaan A. Voors, Dirk J. van Veldhuisen, James K. Liao, Koichi Node, Masashi Fujita, Masatsugu Hori, and Masafumi Kitakaze
Circulation 2004;109:e34, doi:10.1161/01.CIR.0000115211.60667.A6
[Full text]
- Clinician Update
Role of Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
- Carey D. Kimmelstiel and Barry J. Maron
Circulation 2004;109:452-456, doi:10.1161/01.CIR.0000114144.40315.C0
[Full text]
|
|
